Igm Antibody Laboratories manufactures the cellextm qsars-cov-2 rapid igg/igm antibody test reagents distributed by Genprice. The Cellextm Qsars-Cov-2 Rapid Igg/Igm Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Cellextm products are available in stock. Specificity: Cellextm Category: Qsars-Cov-2 Group: Rapid Igg/Igm
Accu-Tell COVID-19 IgG/IgM Rapid Test |
Accu test |
40 tests |
EUR 385.2 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Panbio™ COVID-19 IgG/IgM Rapid Test |
Abbott |
25 Tests/Kit |
EUR 264 |
SARS-CoV-2-IgM/IgG-Test-Kit(Immunochromatographic-Assay) |
EnoGene |
CE-recogniton-IVD |
EUR 350 |
Description: CE recogniton IVD |
SARS-CoV-2 Rapid Antigen Test Nasal |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
SARS-CoV-2 Antigen Rapid Test Kit |
UnScience |
1T |
EUR 9.6 |
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
SARS-CoV-2 Antigen Rapid Test Kit |
UnScience |
25T/kit |
EUR 42 |
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
Rapid Igg/Igm information
Rapid Response COVID-19 Saliva Rapid Antigen Test |
BSV-COV-2C25B |
BioServUK |
25 tests |
Ask for price |
Description: Rapid Response COVID-19 Saliva Rapid Antigen Test |
Human Enterovirus 71 (EV71) IgM Rapid Test Kit |
abx092091-20tests |
Abbexa |
20 tests |
EUR 410.4 |
|
Human Toxoplasma (TOX) IgG Rapid Test Kit |
abx092098-20tests |
Abbexa |
20 tests |
EUR 260.4 |
|
Human Chlamydia Pneumoniae (CP) IgM Rapid Test Kit |
abx092080-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|
Cow Brucella Antibody Rapid Test Kit |
abx092071-40tests |
Abbexa |
40 tests |
EUR 427.2 |
|
Human Mycoplasma Pneumoniae (MP) IgM Rapid Test Kit |
abx092082-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|
Goat Brucella Antibody Rapid Test Kit |
abx092070-40tests |
Abbexa |
40 tests |
EUR 427.2 |
|
Pig Parvovirus Antibody Rapid Test Kit |
abx092074-50tests |
Abbexa |
50 tests |
EUR 385.2 |
|
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
IOV87952 |
INVBIO |
20T/kit |
EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
Human Hepatitis A Virus (HAV) IgM Rapid Test Kit |
abx092085-20tests |
Abbexa |
20 tests |
EUR 276 |
|
Human Hepatitis E Virus (HEV) IgM Rapid Test Kit |
abx092089-20tests |
Abbexa |
20 tests |
EUR 276 |
|
GA COVID-19 Rapid Antigen Test |
BSV-3980 |
BioServUK |
20 tests |
Ask for price |
Description: GA COVID-19 Rapid Antigen Test |
Human Parvovirus B19 (HPV-B19) IgM Rapid Test Kit |
abx092076-20tests |
Abbexa |
20 tests |
EUR 410.4 |
|
Human Rubella Virus (RV) IgG Rapid Test Kit |
abx092097-20tests |
Abbexa |
20 tests |
EUR 260.4 |
|
Human Rabies Virus (HRV) IgG Rapid Test Kit |
abx092100-20tests |
Abbexa |
20 tests |
EUR 410.4 |
|